Project Grant HT94252510333
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This $650,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research conducted by The Trustees of Columbia University's Health Sciences Division. The award, effective April 15, 2025 through April 14, 2028, will fund research on the "Psychiatric Aspects of Post-Traumatic Epilepsy." As a prominent academic research institution, Columbia University leverages its...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical research...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,056,250.00 to The Trustees of Columbia University in the City of New York to conduct research on "Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery". The award has a performance period from Sep 1, 2024 to Aug 31, 2027. The research aims to explore innovative approaches to disease prevention,...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
This $199,115.92 federal Project Grant award was issued on May 15, 2024 by the U.S. Department of Defense Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award supports foundational and applied research across a broad spectrum of scientific and technical domains, with the goal of advancing fundamental knowledge and developing capabilities with potential military applications. The grant recipient is The Trustees of Columbia...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,316,000.00 to support research by The Trustees of Columbia University in the City of New York on advancing the therapeutic target WRN for microsatellite instability-high (MSI-H) cancers. The award has a performance period from August 1, 2025 to July 31, 2029. As a prominent academic research institution, Columbia University...
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,142,336.00 in funding to The Trustees of Columbia University in the City of New York to conduct research on predicting and understanding the side effects of androgen deprivation therapy in veterans with prostate cancer undergoing long-term treatment. The three-year project aims to apply data science approaches to gain insights that can...
The Trustees of Columbia University in the City of New York received a $1.9 million Project Grant award from the Department of the Army Medical Command on August 15, 2022 to fund research on Protein Transduction Therapy for Acute Respiratory Distress Syndrome (ARDS). The research will be conducted through August 14, 2025 in New York, NY under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research with the...
The Trustees of Columbia University in New York City will receive $486,000 under a two-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into novel regulators of lineage plasticity in castration-resistant prostate cancer. Through this funding, Columbia University researchers will investigate medical solutions for prostate cancer that persists despite hormone therapy, with the goal of transforming...